dr. abou-alfa on progress made in hepatocellular carcinoma
Published 4 years ago • 111 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
1:36
dr. abou-alfa on sequencing challenges in metastatic hcc
-
1:22
dr. abou-alfa on ly2157299 in hcc
-
1:09
dr. ghassan abou-alfa on the utility of doxorubicin-eluting beads in hepatocellular carcinoma
-
1:40
dr. ghassan abou-alfa on doxorubicin plus sorafenib in liver cancer
-
1:14
dr. abou-alfa on the ongoing impact and role of regorafenib in hcc
-
2:04
dr. abou-alfa on key trends in hcc research
-
1:21
dr. abou-alfa on sorafenib plus doxorubicin in patients with hcc
-
1:36
dr. abou-alfa discusses new treatment options in hcc
-
1:27
dr. abou-alfa discusses the storm trial in hcc
-
1:44
dr. abou alfa on embolization versus embolization plus systemic therapy in hcc
-
0:53
dr. abou-alfa on the role of immunotherapy in hcc
-
2:05
dr. ghassan abou-alfa on second-line regorafenib in hcc
-
1:33
dr. abou-alfa on trials investigating immunotherapy in hcc
-
1:57
dr. abou-alfa on doxorubicin plus sorafenib in hcc
-
1:20
dr. abou-alfa discusses treatment options in liver cancer
-
1:43
dr. ghassan abou-alfa on met inhibition with tivantinib and cabozantinib in liver cancer
-
1:32
dr. abou-alfa on ly2157299 as treatment for patients with advanced hcc
-
1:18
dr. abou-alfa on the fda approval of cabozantinib in hcc
-
1:44
dr. abou-alfa on key eligibility criteria for the proof trial in cholangiocarcinoma